0001237899-14-000076.txt : 20141119
0001237899-14-000076.hdr.sgml : 20141119
20141119164149
ACCESSION NUMBER: 0001237899-14-000076
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20141117
FILED AS OF DATE: 20141119
DATE AS OF CHANGE: 20141119
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
BUSINESS PHONE: 9143477000
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Terifay Robert J
CENTRAL INDEX KEY: 0001391382
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 141235998
MAIL ADDRESS:
STREET 1: REGENERON PHARMACEUTICALS, INC.
STREET 2: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2014-11-17
0
0000872589
REGENERON PHARMACEUTICALS INC
REGN
0001391382
Terifay Robert J
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
0
1
0
0
SVP Commercial
Common Stock
2014-11-17
4
M
0
48750.0
21.25
A
68779
D
Common Stock
2014-11-17
4
F
0
2578.0
401.75
D
66201
D
Common Stock
2014-11-17
4
F
0
23810.0
401.75
D
42391
D
Common Stock
2014-11-18
4
S
0
62.0
400.45
D
42329
D
Common Stock
2014-11-18
4
S
0
400.0
401.42
D
41929
D
Common Stock
2014-11-18
4
S
0
1500.0
402.71
D
40429
D
Common Stock
2014-11-18
4
S
0
2150.0
403.86
D
38279
D
Common Stock
2014-11-18
4
S
0
3252.0
404.75
D
35027
D
Common Stock
2014-11-18
4
S
0
7278.0
405.85
D
27749
D
Common Stock
2014-11-18
4
S
0
3720.0
406.89
D
24029
D
Common Stock
2014-11-18
4
S
0
2200.0
407.85
D
21829
D
Common Stock
2014-11-18
4
S
0
1800.0
408.62
D
20029
D
Common Stock
1620
I
By 401(k) Plan
Non-Qualified Stock Option (right to buy)
21.25
2014-11-17
4
M
0
48750.0
0.0
D
2019-12-18
Common Stock
48750
0
D
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
Represents volume-weighted average price of sales of 400 shares of Company stock on November 18, 2014 at prices ranging from $401.11 to $401.84. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 18, 2014 at each separate price.
Represents volume-weighted average price of sales of 1,500 shares of Company stock on November 18, 2014 at prices ranging from $402.29 to $403.27. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 18, 2014 at each separate price.
Represents volume-weighted average price of sales of 2,150 shares of Company stock on November 18, 2014 at prices ranging from $403.32 to $404.30. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 18, 2014 at each separate price.
Represents volume-weighted average price of sales of 3,252 shares of Company stock on November 18, 2014 at prices ranging from $404.35 to $405.32. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 18, 2014 at each separate price.
Represents volume-weighted average price of sales of 7,278 shares of Company stock on November 18, 2014 at prices ranging from $405.35 to $406.34. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 18, 2014 at each separate price.
Represents volume-weighted average price of sales of 3,720 shares of Company stock on November 18, 2014 at prices ranging from $406.38 to $407.37. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 18, 2014 at each separate price.
Represents volume-weighted average price of sales of 2,200 shares of Company stock on November 18, 2014 at prices ranging from $407.38 to $408.36. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 18, 2014 at each separate price.
Represents volume-weighted average price of sales of 1,800 shares of Company stock on November 18, 2014 at prices ranging from $408.47 to $408.78. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 18, 2014 at each separate price.
The option became exercisable with respect to all shares underlying the option on December 31, 2012, based upon the satisfaction by the company of certain performance criteria during the period ended December 31, 2012.
/s/**Robert J. Terifay
2014-11-19